Home » Authorities » EDE


Emirates Drug Establishment
The Emirates Drug Establishment (EDE) is the UAE’s federal authority dedicated to regulating pharmaceutical and medical products. Established in September 2023 and brought into force under Federal Decree-Law No. 38 of 2024, it now stands as the country’s sole federal body for this sector, taking over a large share of the pharmaceutical and medical device functions that used to sit with the Ministry of Health and Prevention (MOHAP).
Through a phased transition running into 2025 and 2026, EDE assumed dozens of core services from MOHAP: the registration, listing, and renewal of pharmaceutical products and medical devices, product pricing, manufacturer registration, and the issuance of import permits and export certificates. MOHAP retains overall health policy and licensing functions outside this scope, while EDE runs the day-to-day regulatory processes that determine whether a medicine or medical device can reach the UAE market.
For manufacturers and importers, EDE defines the technical and regulatory dossier a pharmaceutical product, medical device, or IVD must meet before receiving marketing authorization. Atton Tekron works closely within EDE’s regulatory framework and evaluation committees to help medical and pharmaceutical clients streamline classification, technical dossier submission, and registration renewal.




Registers and renews pharmaceutical products, including generics, biologics, and herbal medicines intended for the UAE market.


Registers and lists medical devices and in vitro diagnostics, and oversees the establishments that import or distribute them.


Registers manufacturers and marketing authorization holders, a prerequisite before any of their products can be registered.


Sets and reviews pricing for registered pharmaceutical and medical products sold in the UAE.


Issues permits for importing raw materials and medicines, and certificates for pharmaceutical exports.








EDE is the federal body behind pharmaceutical and medical device regulation in the UAE. It handles the registration, pricing, and renewal processes that decide whether these products reach the market, and it registers the manufacturers and establishments standing behind them. Any pharmaceutical product, medical device, or in vitro diagnostic (IVD) intended for the UAE market falls under EDE’s regulatory oversight.
No. MOHAP is the federal ministry in charge of overall UAE health policy, facility licensing, and public health regulation. EDE is a specialized authority that has since taken over most of the operational side — registration, pricing, renewals — for pharmaceuticals and medical devices, work that used to sit with MOHAP directly. The handover happened in stages through 2025 and 2026. Consequently, certain historical regulations or archived guidance documents may still reference MOHAP for services currently administered by EDE.
Pharmaceuticals, medical devices, in vitro diagnostics, and related health products intended for the UAE market all fall under this. The exact pathway depends on how the product is classified and its risk level. A preliminary regulatory assessment against current EDE guidelines is recommended prior to dossier submission.
Timeline depends on product classification and dossier readiness. A low-risk medical device listing with complete documentation may take a few weeks, whereas pharmaceuticals and higher-risk medical devices (Class IIb/III) undergo comprehensive technical and clinical review, which typically spans several months.
Yes. Foreign manufacturers must appoint a UAE-licensed Marketing Authorization Holder (MAH) or authorized distributor/agent to submit applications and hold the product registration. EDE liaises directly with this local representative for technical reviews, inspections, and renewals.
Pharmaceutical registrations typically run for five years, though some locally manufactured products get a shorter validity period. Renewal means reconfirming the registration against current requirements — checking that the product, the manufacturer, and how it’s made haven’t changed in ways that would affect the original approval. We proactively track expiry timelines and initiate renewal filings well in advance to ensure uninterrupted market availability.
Streamline your pharmaceutical and medical device registration in the UAE. Share your product specs below to receive an expert EDE classification and regulatory clearance roadmap.